Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

6-azauridine

A synthetic triazine analogue of uridine with antimetabolite activity. 6-azauridine inhibits de novo pyrimidine synthesis and DNA synthesis and is converted intracellularly into mono, di, and triphosphate derivatives, which incorporate into RNA and inhibit protein synthesis.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	6-azauracil riboside azauridine riboazauracil
Abbreviation:	6-AZUR
Chemical structure:	1,2,4-triazine-3,5(2H,4H)-dione, 2-beta-D-ribofuranosyl 2-beta-D-ribofuranosyl-1,2,4-triazine-3,5(2H, 4H)-dione 2-beta-D-ribofuranosyl-1,2,4-triazine-3,5(2H,4H)-dione 3,5-dioxo-2,3,4,5-tetrahydro-1,2,4-triazine riboside 6-azauracil 1-riboside 6-azauracil-.beta.-D-riboside 6-azauracil-beta-D-riboside 6-azauracilriboside

6-azauridine

Search NCI's Drug Dictionary